エピソード
-
Cognitive impairment is a significant cause of disability for many people with Multiple Sclerosis. To alleviate or slow the progression of cognitive impairment, non-drug interventions are studied – but which are the most promising?
On this episode, Dr. Mark Bayley interviews Dr. Katherine Knox and Dr. Sarah Morrow about the key findings from MSBEST’s systematic review on non-drug interventions evaluating cognitive impairment in MS. They discuss which interventions may help, clinical implications and future directions. You may find the complete MSBEST systematic reviews on interventions for cognition on our website: msbest.ca.
MSBEST systematic reviews cover topics that are important to the independence and quality of life of people living with MS. Reviews and podcasts target health care providers and researchers to advance evidence-based MS care.
-
Cognitive impairment is a significant cause of disability for many people with Multiple Sclerosis (MS). To alleviate or slow the progression of cognitive impairment, pharmacological interventions (drugs, supplements, and alternative therapies) are studied – but do they work and which are most promising? On this episode, Dr. Katherine Knox and Dr. Sarah Morrow share key findings from MSBEST’s systematic review on pharmacological interventions tested for their effects on cognitive impairment in MS. They discuss which interventions may help, which don’t work, and where more research is needed.
You can find the complete MSBEST systematic review of pharmacological interventions for cognition on our website: msbest.ca.
MSBEST develops comprehensive systematic reviews in multiple sclerosis rehabilitation to inform evidence-based care and improve the lives of people living with MS.
-
エピソードを見逃しましたか？
